RPRX Share Price

Open 1.60 Change Price %
High 1.60 1 Day -0.03 -1.95
Low 1.49 1 Week -0.26 -14.69
Close 1.51 1 Month -0.26 -14.69
Volume 312547 1 Year 0.16 11.85
52 Week High 3.48
52 Week Low 0.00
RPRX Important Levels
Resistance 2 1.61
Resistance 1 1.57
Pivot 1.53
Support 1 1.45
Support 2 1.41
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Repros Therapeutics Inc. (NASDAQ: RPRX)

RPRX Technical Analysis 4
As on 9th Dec 2016 RPRX Share Price closed @ 1.51 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.68 & Strong Sell for SHORT-TERM with Stoploss of 1.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
RPRX Target for December
1st Target up-side 2.14
2nd Target up-side 2.39
3rd Target up-side 2.64
1st Target down-side 1.44
2nd Target down-side 1.19
3rd Target down-side 0.94
RPRX Other Details
Segment EQ
Market Capital 240998304.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.reprosrx.com
RPRX Address
RPRX
2408 Timberloch Place
Suite B-7
The Woodlands, TX 77380
United States
Phone: 281-719-3400
Fax: 281-719-3446
RPRX Latest News
Interactive Technical Analysis Chart Repros Therapeutics Inc. ( RPRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Repros Therapeutics Inc.
RPRX Business Profile
Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.